Remove 2014 Remove Access Remove Epilepsy
article thumbnail

Mississippi: Medical Cannabis Initiative Certified for 2020 Ballot

NORML

A proposed measure legalizing medical cannabis access in Mississippi has qualified for the 2020 ballot. The measure places no limit on the number of dispensaries and mandates that local municipalities “shall not impair the availability of and reasonable access to medical marijuana.”

Epilepsy 233
article thumbnail

The Latin American Cannabis Landscape – Part Two: Regulated Markets and Patient Access

CannaTech

Medical cannabis continued to pop up across the region year after year: imports in Brazil began in 2014, trials started in Chile in 2014, regulations were implemented in Colombia and Jamaica in 2015, the same followed in the Cayman Islands and parts of Argentina in 2016, Paraguay in 2017, and the list carries on from 2018 to date.

Access 89
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis laws in South Carolina

The Cannigma

It expanded qualifying conditions and allowed patients to access select THC products through state-licensed dispensaries. In 2014, prior to federal CBD legalization, the governor signed Julian’s Law which created access to low-THC/ high-CBD oil for qualified patients. It failed in the state House. CBD regulations.

Law 118
article thumbnail

Every Florida Medical Marijuana Law You Need to Know

CannaMD

MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Once you begin medical marijuana treatment, the only people that will have access to your records will be: Your doctor.

Law 126
article thumbnail

Answer of the Day for May 17, 2022

TheAnswerPage

According to a presentation at the 2014 annual meeting of the American Epilepsy Society, an increasing dose of CBD was associated with significant increases in serum levels of topiramate, rufinamide, and N-desmethylclobazam. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

article thumbnail

Answer of the Day for Aug 16, 2021

TheAnswerPage

According to a presentation at the 2014 annual meeting of the American Epilepsy Society, an increasing dose of CBD was associated with significant increases in serum levels of topiramate, rufinamide, and N-desmethylclobazam. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.

article thumbnail

Answer of the Day for Jun 11, 2021

TheAnswerPage

According to a presentation at the 2014 annual meeting of the American Epilepsy Society, an increasing dose of CBD was associated with significant increases in serum levels of topiramate, rufinamide, and N-desmethylclobazam. Presented at the annual meeting of the American Epilepsy Society, Seattle, December 5–9, 2014; abstract.